« Back to Record
Taieb, J., Folprecht, G., Van Laethem, J.-L., Lepage, C., Emile, J.-F., Laurent-Puig, P., Zaanan, A., Le Malicot, K., Julié, C., Blons, H., Mineur, L., Bennouna, J., Tabernero, J., & Mini, E. (2016). Prognostic effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab. JAMA oncology, 2(5), 643-653. doi:10.1001/jamaoncol.2015.5225
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247825



